Join our daily newsletter At The Bell to receive exclusive market insights
The ASX has been down 0.4% at around 8,205 points in morning trade.
Alterity Therapeutics (ASX:ATH) has been the most watched on HotCopper this morning on news the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its orphan drug for the treatment of Multiple System Atrophy.
Alterity Therapeutics has been trading up 5.5% at 1 cent.
Gold Road Resources (ASX:GOR) has also been trending after entering into a Scheme Implementation Deed with South Africa and New York listed Gold Fields. The deal will see Gold Fields buy 100 per cent of the shares in Gold Road.
Gold Road has been up 9.4% at $3.25.
And, finally Hazer Group (ASX:HZR) has kicked off a binding Alliance Agreement with U.S. juggernaut Kellogg Brown and Root (NYSE: KBR), for the licensing of Hazer’s proprietary methane pyrolysis technology.
Hazer Group has been up 8.3% at 39 cents.
